Active ingredient
Mirikizumab
5 finished FDA listings contain Mirikizumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- MIRIKIZUMAB
- Dosage forms
- Injection, Solution
- Routes
- Intravenous, Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 100 mg/ml · 20 mg/ml
- Brand names in FDA listings
- Omvoh
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2668384
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 761279 | ELI LILLY AND CO | 2023-10-26 | 5 |
Official labeling on DailyMed
- OMVOH (MIRIKIZUMAB-MRKZ) INJECTION, SOLUTION OMVOH (MIRIKIZUMAB-MRKZ) KIT [ELI LILLY AND COMPANY] · version 19 · 2026-08-11
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.